Rabia Aydogan Baykara, Tugba Izci Duran, Melih Pamukcu

Disease activation and laboratory parameters in Fibromyalgia Syndrome: Relationship with C-reactive protein/albumin ratio, neutrophil/lymphocyte ratio, mean platelet volume

Fibromyalgia syndrome (FMS) is a chronic, widespread painful disease with unexplained etiopathogenesis and somatic-psychic findings. Unlike inflammatory rheumatic diseases, there are no specific laboratory parameters in FMS. In our study, we aimed to investigate the relationship between inflammatory markers and FMS activation scales. Eighty patients aged 18-65 years, diagnosed with FSM according to the American College of Rheumatology (ACR) 1990 criteria, were evaluated retrospectively. 61 healthy controls matched for sex, age, and body mass index (BMI) constituted the control group. In addition to the demographic data of the patients, the fibromyalgia impact questionnaire (FIQ) score, visual analog scale (VAS) fatigue score, VAS pain score, number of tender points, C- reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin, and complete blood count values were evaluated and compared statistically. FIQ, VAS pain, and VAS fatigue score, number of tender points were significantly higher in the patient group (p

PDF

___

1. Bair MJ, Krebs EE. Fibromyalgia. Ann Intern Med. 2020 ;3;172:33-48.
2. Clauw DJ. Fibromyalgia: a clinical review. Jama. 2014 Apr 16;311:1547- 55.
3. D'Agnelli S, Arendt-Nielsen L, Gerra MC, et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Mol Pain. 2019;15:1744806918819944.
4. García Rodríguez DF, Abud Mendoza C. Physiopathology of fibromyalgia. Reumatol Clin. 2020 May-Jun;16(3):191-4. PubMed PMID: 32279983. Epub 2020/04/14. Fisiopatología de la fibromialgia. eng spa.
5. Sluka K, Clauw D. Neurobiology of fibromyalgia and chronic widespread pain. J Neurosci. 2016 06/01;338.
6. Colglazier CL, Sutej PG. Laboratory testing in the rheumatic diseases: a practical review. South Med J. 2005 ;98:185-91.
7. Castell JV, Gómez-Lechón MJ, David M, Fabra R, et al. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology (Baltimore, Md). 1990;12:1179-86.
8. Domínguez de Villota E, Mosquera JM, Rubio JJ, et al. Association of a low serum albumin with infection and increased mortality in critically ill patients. Intensive Care Med. 1980;7:19-22.
9. Yang WM, Zhang WH, Ying HQ, Xu YM, Zhang J, Min QH, et al. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol. 2018;62:293-8.
10. Gibson DJ, Hartery K, Doherty J, et al. CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis. J Clin Gastroenterol. 2018;52:48-52. .
11. Zeb A, Khurshid S, Bano S, et al. The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis. Cureus. 2019;29;11:6025.
12. Jung JY, Lee E, Suh CH. Neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio are associated with disease activity in polymyalgia rheumatica.J Clin Lab Anal. 2019;33:23000.
13. Soliman WM, Sherif NM, Ghanima IM, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis. Clin Rheumatol. 2020;16:255-61.
14. Hammad M, Shehata OZ, Abdel-Latif SM, et al. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use? Clin Rheumatol. 2018;37:2811-7.
15. Pamukcu M, Duran TI. Could C-Reactive Protein/Albumin Ratio be an Indicator of Activation in Axial Spondyloarthritis? J Coll Physicians Surg Pak. 2021;30:537-41.
16. Kucuk A, Uslu AU, Ugan Y, et al. Neutrophil-to-lymphocyte ratio is involved in the severity of ankylosing spondylitis. Bratisl Lek Listy. 2015;116:722-5.
17. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157-61.
18. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001;96:776-81.
19. Milovanovic M, Nilsson E, Järemo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta. 2004;343:237-40.
20. Metyas SK, Solyman JS, Arkfeld DG. Inflammatory Fibromyalgia: Is it Real? Curr Rheumatol Rev. 2015;11:15-7.
21. Feinberg T, Sambamoorthi U, Lilly C, et al. Potential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey. BMC Musculoskelet Disord. 2017;18:294.
22. Xiao Y, Haynes WL, Michalek JE, et al. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int. 2013;33:1259-64.
23. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum. 1990;33:160-72.
24. Burckhardt CS, Clark SR, Bennett R. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol. 1991;18:728-33.
25. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20:9-12.
26. Price DD, McGrath PA, Rafii A,et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56.
27. Pollard LC, Choy EH, Gonzalez J, et al. Fatigue in rheumatoid arthritis reflects pain, not disease activity. J Rheumatol. 2006;45:885-9.
28. Muz G, Taşcı S. Effect of aromatherapy via inhalation on the sleep quality and fatigue level in people undergoing hemodialysis. Appl Nurs Res. 2017;37:28-35.
29. Hawker GA, Mian S, Kendzerska T, et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 ;11:S240-52.
30. Uzunoglu S. Cicin I. Approach to pain in cancer patients. Clin Dev. 2011;24:14-20.
31. Rodriguez-Pintó I, Agmon-Levin N, Howard A,et al. Fibromyalgia and cytokines. Immunol. Lett. 2014;161:200-3.
32. Andrés-Rodríguez L, Borràs X, Feliu-Soler A, et al. Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and metaregression. Brain Behav Immun. 2020;87:881-9.
33. Uçeyler N, Häuser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011;12:245.
34. Kösehasanoğulları M, Yılmaz N. A Fibromyalgia Syndrome and Neuropathic Pain. Aegean J Med Sci. 2018;1:31.
35. Malhotra D, Saxena AK, Dar SA, et al. Evaluation of cytokine levels in fibromyalgia syndrome patients and its relationship to the severity of chronic pain†. J Musculoskel Pain. 2012;20:164-9.
36. B J. The Blood-vessels of the Human Skin and their Responses. Nature. 1928;122:5-6.
37. Wallengren J, Möller H. The effect of capsaicin on some experimental inflammations in human skin. Acta Derm Venereol. 1986;66:375-80.
38. Schmelz M, Michael K, Weidner C, et al. Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport. 2000;28:645-8.
39. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. General pharmacology. Gen Pharmacol. 1998;30:5-11.
40. Chiu IM, von Hehn CA, Woolf CJ. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci. 2012;15:1063-7.
41. Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008;437:199- 202.
42. Pay S, Calgüneri M, Calişkaner Z, Dinç A, et al. Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia. Nagoya J Med Sci. 2000;63:115-22.
43. Caro XJ. Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum. 1984;27:1174-9.
44. Huygen F, O’Connell N, Harden N. Complex regional pain syndrome: state of the art. In: Raja SN, Sommer CL, editors. Pain 2014 Refresher Courses, 15th World Congress on Pain. Washington: IASP Press; 2014 Washington, USA , p. 259–72.